Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999

Sexually Transmitted Diseases

Volumn 29, Issue 11, 2002, Pages 668-673

  Trees, David L ^d,e   Sirivongrangson, Pachara ^a   Schultz, Abbigail J ^d   Buatiang, Anukul ^a   Neal, Sandra W ^d   Knapp, Joan S ^d   Kilmarx, Peter H ^b,c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b HIV/AIDS Collaboration   (Thailand)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; LIPOPROTEIN; OFLOXACIN; OUTER MEMBRANE PROTEIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITY; DNA SEQUENCE; GENE MUTATION; GONORRHEA; GYRA GENE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PARC GENE; POLYMERASE CHAIN REACTION; SEROTYPE; THAILAND;

EID: 0036842358     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200211000-00009     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. 1998 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1998; 47(RR-1):59-63.
2. Fox KK, Knapp JS, Holmes KK, et al. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: The emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis 1997; 175:1396-1403.
3. Knapp JS, Fox KK, Trees DL, Whittington WL. Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis 1997; 3:33-39.
4. WHO Western Pacific Antimicrobial Surveillance Programme. Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treatment of gonorrnea, 1997. CDI 1998; 13:288-291.
5. Tanaka M, Sakuma S, Takahashi K, et al. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro. Sex Transm Infect 1998; 74:59-62.
6. Belland RJ, Morrison SG, Ison C, Huang WM. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 1994; 14:371-380.
7. Deguchi T, Yasuda M, Asano M, et al. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1995; 29:561-563.
8. Deguchi T, Yasuda M, Nakano M, et al. Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother 1996; 40:1020-1023.
9. Ferrero L, Cameron B, Manse B, et al. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: A primary target for fluoroquinolones. Mol Microbiol 1994; 13:641-653.
10. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990; 34:1271-1272.
11. Deguchi T, Yasuda M, Nakano M, et al. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1996; 40:2437-2438.
12. Trees DL, Sandul AL, Whittington WL, Knapp JS. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1998; 42:2103-2105.
13. Trees DL, Sandul AL, Peto-Mesola V, et al. Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States. Int J Antimicrob Agents 1999; 12:325-332.
14. Knapp JS, Tam MR, Nowinski RC, Holmes KK, Sandström EG. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984; 150:44-48.
15. Meyers JA, Sanchez D, Elwell S, Falkow S. Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid. J Bacteriol 1976; 127:1529-1537.
16. Short HB, Ploscowe VB, Weiss JS, Young FE. Rapid method for auxotyping multiple strains of Neisseria gonorrhoeae. J Clin Microbiol 1977; 6:244-248.
17. National Committee for Clinical Laboratory Standards. Approved Standard M7-A3. Methods for dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
18. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. M100-S8. Wayne. Pennsylvania: National Committee for Clinical Laboratory Standards, 1998.
19. Rice RJ, Knapp JS. Antimicrobial susceptibilities of Neisseria gonorrhoeae representing five distinct resistance phenotypes. Antimicrob Agents Chemother 1994; 38:155-158.
20. Rice RJ, Knapp JS. Susceptibility of Neisseria gonorrhoeae associated ith pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents. Antimicrob Agents Chemother 1994; 38:1688-1691.
21. Knapp JS, Washington JA II, Doyle LJ, Neal SW, Parekh MC, Rice RJ. Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother 1994; 38: 2194-2196.
22. Trees DL, Schultz AJ, Knapp JS. Use of the neisserial lipoprotein (Lip) for subtyping Neisseria gonorrhoeae. J Clin Microbiol 2000; 38:2914-2916.
23. Deguchi T, Yasuda M, Nakano M, et al. Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J Clin Microbiol 1996; 34:2255-2258.
24. Deguchi T, Yasuda M, Nakano M, et al. Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones. J Clin Microbiol 1997; 35:948-950.
25. Knapp JS, Wongba C, Limpakarnjanarat K, et al. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Sex Transm Dis 1997; 24:1-6.
26. Venereal Disease Division Annual Report, 2000. Bangkok: Ministry of Public Health, 2001.
27. Kilmarx PH, Supawitkul S, Wankrairoj M, et al. Explosive spread and effective control of human immunodeficiency virus in northernmost Thailand: The epidemic in Chiang Rai province, 1988-99. AIDS 2000; 14:2731-2740.
28. van Griensven GJP, Supawitkul S, Kilmarx PH, et al. Rapid assessment of sexual behavior, drug use, HIV, and sexually transmitted diseases in northern Thai youth, using audio-computer-assisted self-interviewing and noninvasive specimen collection. Pediatrics 2001; 108:E13.